img

Global In Situ Hybridization Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global In Situ Hybridization Market Research Report 2024

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.
According to MRAResearch’s new survey, global In Situ Hybridization market is projected to reach US$ 705 million in 2033, increasing from US$ 545.2 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Situ Hybridization market research.
North America is expected to account for the largest share of the market in 2018. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, government initiatives, increasing prevalence and diagnosis of cancer in the U.S. and Canada, and increasing adoption of companion diagnostics. Increased adoption of companion diagnostics is attributed to the development and launch of newer therapeutic agents. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In Situ Hybridization market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott Laboratories
Roche
Thermo Fisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio Sb
Segment by Type
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization

Segment by Application


Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In Situ Hybridization report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Situ Hybridization Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Fluorescence In Situ Hybridization (FISH)
1.2.3 Chromogenic In Situ Hybridization
1.3 Market by Application
1.3.1 Global In Situ Hybridization Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer Diagnosis
1.3.3 Immunology
1.3.4 Neuroscience
1.3.5 Cytology
1.3.6 Infectious Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Situ Hybridization Market Perspective (2018-2033)
2.2 In Situ Hybridization Growth Trends by Region
2.2.1 Global In Situ Hybridization Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 In Situ Hybridization Historic Market Size by Region (2018-2023)
2.2.3 In Situ Hybridization Forecasted Market Size by Region (2024-2033)
2.3 In Situ Hybridization Market Dynamics
2.3.1 In Situ Hybridization Industry Trends
2.3.2 In Situ Hybridization Market Drivers
2.3.3 In Situ Hybridization Market Challenges
2.3.4 In Situ Hybridization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Situ Hybridization Players by Revenue
3.1.1 Global Top In Situ Hybridization Players by Revenue (2018-2023)
3.1.2 Global In Situ Hybridization Revenue Market Share by Players (2018-2023)
3.2 Global In Situ Hybridization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Situ Hybridization Revenue
3.4 Global In Situ Hybridization Market Concentration Ratio
3.4.1 Global In Situ Hybridization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Situ Hybridization Revenue in 2022
3.5 In Situ Hybridization Key Players Head office and Area Served
3.6 Key Players In Situ Hybridization Product Solution and Service
3.7 Date of Enter into In Situ Hybridization Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Situ Hybridization Breakdown Data by Type
4.1 Global In Situ Hybridization Historic Market Size by Type (2018-2023)
4.2 Global In Situ Hybridization Forecasted Market Size by Type (2024-2033)
5 In Situ Hybridization Breakdown Data by Application
5.1 Global In Situ Hybridization Historic Market Size by Application (2018-2023)
5.2 Global In Situ Hybridization Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America In Situ Hybridization Market Size (2018-2033)
6.2 North America In Situ Hybridization Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America In Situ Hybridization Market Size by Country (2018-2023)
6.4 North America In Situ Hybridization Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Situ Hybridization Market Size (2018-2033)
7.2 Europe In Situ Hybridization Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe In Situ Hybridization Market Size by Country (2018-2023)
7.4 Europe In Situ Hybridization Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Situ Hybridization Market Size (2018-2033)
8.2 Asia-Pacific In Situ Hybridization Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific In Situ Hybridization Market Size by Region (2018-2023)
8.4 Asia-Pacific In Situ Hybridization Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Situ Hybridization Market Size (2018-2033)
9.2 Latin America In Situ Hybridization Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America In Situ Hybridization Market Size by Country (2018-2023)
9.4 Latin America In Situ Hybridization Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Situ Hybridization Market Size (2018-2033)
10.2 Middle East & Africa In Situ Hybridization Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa In Situ Hybridization Market Size by Country (2018-2023)
10.4 Middle East & Africa In Situ Hybridization Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories In Situ Hybridization Introduction
11.1.4 Abbott Laboratories Revenue in In Situ Hybridization Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche In Situ Hybridization Introduction
11.2.4 Roche Revenue in In Situ Hybridization Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific In Situ Hybridization Introduction
11.3.4 Thermo Fisher Scientific Revenue in In Situ Hybridization Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck In Situ Hybridization Introduction
11.4.4 Merck Revenue in In Situ Hybridization Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies In Situ Hybridization Introduction
11.5.4 Agilent Technologies Revenue in In Situ Hybridization Business (2018-2023)
11.5.5 Agilent Technologies Recent Development
11.6 Perkin Elmer
11.6.1 Perkin Elmer Company Detail
11.6.2 Perkin Elmer Business Overview
11.6.3 Perkin Elmer In Situ Hybridization Introduction
11.6.4 Perkin Elmer Revenue in In Situ Hybridization Business (2018-2023)
11.6.5 Perkin Elmer Recent Development
11.7 Danaher
11.7.1 Danaher Company Detail
11.7.2 Danaher Business Overview
11.7.3 Danaher In Situ Hybridization Introduction
11.7.4 Danaher Revenue in In Situ Hybridization Business (2018-2023)
11.7.5 Danaher Recent Development
11.8 Exiqon
11.8.1 Exiqon Company Detail
11.8.2 Exiqon Business Overview
11.8.3 Exiqon In Situ Hybridization Introduction
11.8.4 Exiqon Revenue in In Situ Hybridization Business (2018-2023)
11.8.5 Exiqon Recent Development
11.9 Biogenex Laboratories
11.9.1 Biogenex Laboratories Company Detail
11.9.2 Biogenex Laboratories Business Overview
11.9.3 Biogenex Laboratories In Situ Hybridization Introduction
11.9.4 Biogenex Laboratories Revenue in In Situ Hybridization Business (2018-2023)
11.9.5 Biogenex Laboratories Recent Development
11.10 Advanced Cell Diagnostics
11.10.1 Advanced Cell Diagnostics Company Detail
11.10.2 Advanced Cell Diagnostics Business Overview
11.10.3 Advanced Cell Diagnostics In Situ Hybridization Introduction
11.10.4 Advanced Cell Diagnostics Revenue in In Situ Hybridization Business (2018-2023)
11.10.5 Advanced Cell Diagnostics Recent Development
11.11 Bio Sb
11.11.1 Bio Sb Company Detail
11.11.2 Bio Sb Business Overview
11.11.3 Bio Sb In Situ Hybridization Introduction
11.11.4 Bio Sb Revenue in In Situ Hybridization Business (2018-2023)
11.11.5 Bio Sb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In Situ Hybridization Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Fluorescence In Situ Hybridization (FISH)
Table 3. Key Players of Chromogenic In Situ Hybridization
Table 4. Global In Situ Hybridization Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global In Situ Hybridization Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global In Situ Hybridization Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global In Situ Hybridization Market Share by Region (2018-2023)
Table 8. Global In Situ Hybridization Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global In Situ Hybridization Market Share by Region (2024-2033)
Table 10. In Situ Hybridization Market Trends
Table 11. In Situ Hybridization Market Drivers
Table 12. In Situ Hybridization Market Challenges
Table 13. In Situ Hybridization Market Restraints
Table 14. Global In Situ Hybridization Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global In Situ Hybridization Market Share by Players (2018-2023)
Table 16. Global Top In Situ Hybridization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Situ Hybridization as of 2022)
Table 17. Ranking of Global Top In Situ Hybridization Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by In Situ Hybridization Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In Situ Hybridization Product Solution and Service
Table 21. Date of Enter into In Situ Hybridization Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In Situ Hybridization Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global In Situ Hybridization Revenue Market Share by Type (2018-2023)
Table 25. Global In Situ Hybridization Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global In Situ Hybridization Revenue Market Share by Type (2024-2033)
Table 27. Global In Situ Hybridization Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global In Situ Hybridization Revenue Market Share by Application (2018-2023)
Table 29. Global In Situ Hybridization Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global In Situ Hybridization Revenue Market Share by Application (2024-2033)
Table 31. North America In Situ Hybridization Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America In Situ Hybridization Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America In Situ Hybridization Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe In Situ Hybridization Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe In Situ Hybridization Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe In Situ Hybridization Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific In Situ Hybridization Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific In Situ Hybridization Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific In Situ Hybridization Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America In Situ Hybridization Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America In Situ Hybridization Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America In Situ Hybridization Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa In Situ Hybridization Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa In Situ Hybridization Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa In Situ Hybridization Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories In Situ Hybridization Product
Table 49. Abbott Laboratories Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche In Situ Hybridization Product
Table 54. Roche Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific In Situ Hybridization Product
Table 59. Thermo Fisher Scientific Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck In Situ Hybridization Product
Table 64. Merck Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Agilent Technologies Company Detail
Table 67. Agilent Technologies Business Overview
Table 68. Agilent Technologies In Situ Hybridization Product
Table 69. Agilent Technologies Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 70. Agilent Technologies Recent Development
Table 71. Perkin Elmer Company Detail
Table 72. Perkin Elmer Business Overview
Table 73. Perkin Elmer In Situ Hybridization Product
Table 74. Perkin Elmer Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 75. Perkin Elmer Recent Development
Table 76. Danaher Company Detail
Table 77. Danaher Business Overview
Table 78. Danaher In Situ Hybridization Product
Table 79. Danaher Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 80. Danaher Recent Development
Table 81. Exiqon Company Detail
Table 82. Exiqon Business Overview
Table 83. Exiqon In Situ Hybridization Product
Table 84. Exiqon Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 85. Exiqon Recent Development
Table 86. Biogenex Laboratories Company Detail
Table 87. Biogenex Laboratories Business Overview
Table 88. Biogenex Laboratories In Situ Hybridization Product
Table 89. Biogenex Laboratories Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 90. Biogenex Laboratories Recent Development
Table 91. Advanced Cell Diagnostics Company Detail
Table 92. Advanced Cell Diagnostics Business Overview
Table 93. Advanced Cell Diagnostics In Situ Hybridization Product
Table 94. Advanced Cell Diagnostics Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 95. Advanced Cell Diagnostics Recent Development
Table 96. Bio Sb Company Detail
Table 97. Bio Sb Business Overview
Table 98. Bio Sb In Situ Hybridization Product
Table 99. Bio Sb Revenue in In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 100. Bio Sb Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Situ Hybridization Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global In Situ Hybridization Market Share by Type: 2022 VS 2033
Figure 3. Fluorescence In Situ Hybridization (FISH) Features
Figure 4. Chromogenic In Situ Hybridization Features
Figure 5. Global In Situ Hybridization Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global In Situ Hybridization Market Share by Application: 2022 VS 2033
Figure 7. Cancer Diagnosis Case Studies
Figure 8. Immunology Case Studies
Figure 9. Neuroscience Case Studies
Figure 10. Cytology Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. In Situ Hybridization Report Years Considered
Figure 13. Global In Situ Hybridization Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global In Situ Hybridization Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global In Situ Hybridization Market Share by Region: 2022 VS 2033
Figure 16. Global In Situ Hybridization Market Share by Players in 2022
Figure 17. Global Top In Situ Hybridization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Situ Hybridization as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by In Situ Hybridization Revenue in 2022
Figure 19. North America In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America In Situ Hybridization Market Share by Country (2018-2033)
Figure 21. United States In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe In Situ Hybridization Market Share by Country (2018-2033)
Figure 25. Germany In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific In Situ Hybridization Market Share by Region (2018-2033)
Figure 33. China In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America In Situ Hybridization Market Share by Country (2018-2033)
Figure 41. Mexico In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa In Situ Hybridization Market Share by Country (2018-2033)
Figure 45. Turkey In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia In Situ Hybridization Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 51. Agilent Technologies Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 52. Perkin Elmer Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 53. Danaher Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 54. Exiqon Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 55. Biogenex Laboratories Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 56. Advanced Cell Diagnostics Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 57. Bio Sb Revenue Growth Rate in In Situ Hybridization Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed